|
[1]Gripon P, Diot C, Theze N, et al.Hepatitis B virus infection of a-dult human hepatocytes cultured in the presence of dimethylsulfoxide[J].Virol, 1988, 62∶4136-4143.
|
|
[2]Wieland S, Spangenberg F, Thimme R, et al.Expansion and con-traction of the hepatitis B virus transcriptional template in infectedchimpanzees[J].Proc Natl Acad Sci USA, 2004, 101∶2129-2134.
|
|
[3]Josef K, Michael K, Gerhard P, et al. Central Role of a Serine Phosphorylation Site within Duck Hepatitis B Virus Core Protein for Capsid Trafficking and Genome Release[J].Biol Chem, 2003, 278∶28123-28129.
|
|
[4]Lars S, Anneke F, Ariane K, et al.Identification of a structural mo-tif crucial for infectivity of Hepatitis B viruses[J].Virol, 2006, 103∶6730-6734.
|
|
[5]Boni C, Penna A, Ogg G, et al. Lamivudine treatment can overcome cytotoxic T-cell Hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy[J].Hepatology, 2001, 33∶963-971.
|
|
[6]Gish R, Leung W, Wright H, et al.Dose range study of pharmacoki-netics, safety, and preliminary antiviral activity of emtricitabine in a-dults with hepatitis B virus infection[J].Antimicrob Agents Chem, 2002, 46∶1734-1740.
|
|
[7]Yong-Yuan Zh, Daniel P, Jesse S, et al.Age-Related Differ-ences in Amplification of Covalently Closed Circular DNA at EarlyTimes after Duck Hepatitis B Virus Infection of Ducks[J].Virol, 2005, 79∶9896-9903.
|
|
[8]Marc F, Mire Le, Darren S, et al.Covalently Closed Circular DNAIs the Predominant Form of Duck Hepatitis B Virus DNA That Per-sists following Transient Infection[J].Virol, 2005, 79∶12-242-12252.
|
|
[9]Haitao G, William S, Mason E, et al.Identification and Character-ization of Avihepadnaviruses Isolated from Exotic Anseriformes Main-atined in Captivity[J].Virol, 2005, 5∶2729-2742.
|
|
[10]Halpern M, England J, Deery D, et al.Viral nucleic acid synthesisand antigen accumulation in pancreas and kidney of Pekin ducks in-fected with duck hepatitis B virus[J].Proc Natl Acad Sci USA, 1983, 80∶4865-4869.
|
|
[11]Marinos G, Torre F, Gunther S, et al.Hepatitis B virus variantswith core gene deletions in the evolution of chronic hepatitis B infec-tion[J].Gastroenterology, 1996, 111∶183-192.
|
|
[12]Mengji Lu, Hilken G, Dongliang Y, et al. Replication of Naturally Occurring Woodchuck Hepatitis Virus Deletion Mutants in Primary Hepatocyte Cultures and after Transmission to Naive Woodchucks[J].Virol, 2001, 75∶3811-3818.
|
|
[13]Chee-kin H, Bowden S, Jackson K, et al.Clinical significance ofintrahepatic hepatitis B virus covalently closed circular DNA in chro-nic hepatitis B patients who received cytotoxic chemotherapy[J].Blood, 2005, 105∶2616-2617.
|
|
[14]Foster W, Miller S, Marion P, et al. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection. Antimicrob[J].Agents Chemother, 2003, 47∶2624-2635.
|
|
[15]Wendy K, Foster P, Darren S. Effect of Antiviral Treatment with Entecavir on Age-and Dose-Related Outcomes of Duck Hepatitis B Virus Infection[J].Virol, 2005, 79∶5819-5832.
|
|
[16]William S, Mason R, Summers J. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection[J].Virol, 2005, 102∶1139-1144.
|
|
[17]Marcellin P, Mommeja H, Sacks S, et al.AphaseⅡdose-esca-lating trial of clevudine in patients with chronic hepatitis B[J].Hep-atology, 2004, 40∶140-148.
|
|
[18]Delaney W, Yang H, Miller M, et al.Combinations of adefovirwith nucleoside analogs produce additive antiviral effects against hep-atitis B virus in vitro[J].Antimicrob AgentsChem, 2004, 48∶3702-3710.
|
|
[19]Jacquard A, Nassal M, Pichoud C, et al.Effect of a combination ofclevudine and emtricitabine with adenovirus-mediated delivery ofgamma interferon in the woodchuck model of hepatitis B virus infec-tion[J].Antimicrobial Agents and Chemotherapy, 2004, 48∶2683-2692.
|
PDF下载 ( 133 KB)
本文二维码
下载:
